CLINICAL_TRIALS
trial_result
· 2021-10-06
Clinical Trial Update: Teduglutide for Enterocutaneous Fistula (ECF) [Phase 2]
Summary
Phase 2 trial of teduglutide for postoperative enterocutaneous fistula has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Daniel Dante Yeh | Conditions: Postoperative Fistula | Phase 2 | Status: COMPLETED | Results posted: 2021-10-06